Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Leiden University Medical Center and Inova Diagnostics have completed a worldwide license agreement for technology developed at LUMC to detect antibodies to carbamylated proteins (anti-CarP). This technology represents an important advance in diagnosing rheumatoid arthritis (RA).
Vector Laboratories has added to its mouse-on-mouse (MOM) family of detection reagents the MOM ImmPress peroxidase polymer kit. It allows the use of mouse primary antibodies on mouse tissue without background staining, by using a sensitive, one-step, non-biotin MOM ImmPress polymer reagent. The reagent also provides a time savings in the detection protocol, since it is ready to use in one step.
MidSci’s Bio-Assembler kits use magnetic levitation to culture cells in three dimensions. Available in single-, six-, and 24-well configurations, the kits supply magnetic drivers, low-binding dishes/ plates, and Nanoshuttle-PL solution in quantities and volumes appropriate to kit size.
Sarstedt’s S-Monovette is an enclosed multiple-sampling blood collection system. All tubes are plastic and have screw caps, which minimizes the risk of breakage and aerosol formation when caps are removed. The screw caps have a thin, recessed membrane that is easy to puncture and protects users from residual blood droplets.
Trovagene expects to achieve analytical and clinical validation of its urine-based HPV carrier screening test this month in its CLIA laboratory. When validation is complete, the test will be available to clinicians and their patients.
Selventa’s Systems Diagnostics, or SysDx, will be a novel class of diagnostic tests that consist of “multi-omic” biomarkers selected through analysis of a patient’s biological profile, including genomic, epigenomic, transcriptomic, proteomic, metabolomic, and electronic medical record information. From the data, Selventa will generate a differentiated and clinically relevant report that physicians and patients can use to improve therapy selection.
Hardy Diagnostics’ Arcanobacterium selective agar is a selective medium for the isolation of Arcanobacterium haemolyticum, especially from respiratory specimens.
Spot Imaging Solutions’ ultrasensitive Spot Pursuit USB digital camera combines superb image quality with excellent temporal resolution for rapid time-lapse recordings. This enables researchers to document live cells and photobleaching fluorescence specimens easily.
Thermo Fisher Scientific has expanded its suite of cryopreservation reagents with the HyClone HyCryo and HyCryo-Stem cryopreservation media, enabling researchers to maximize the preservation, recovery, and growth of post-thaw cells for general cell culture and stem-cell applications.
Alpha-Tec Systems’ NAC-PAC (Nacetylcysteine-package) EA3 offers a complete specimen preparation reagent system to digest, buffer, and resuspend patient samples for lab analysis of Mycobacterium spp. The reagents in NAC-PAC EA3 improve the efficiency of acid-fast bacilli diagnostics and reduce the need to reprocess samples by controlling pH throughout the entire specimen preparation procedure with an integrated pH indicator to ensure a neutral patient sample is achieved.
